In summary, we herein identified PLA2G7 as a biomarker that is upregulated in DLBCL and that is related to the enhancement of DLBCL cell proliferation, invasion, and tumor microenvironmental composition. This evidence concerns the gene PLA2G7 and diffuse large B-cell lymphoma.